+++++++++++++
What Is Enzyme?
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions.[1][2] In enzymatic reactions, the molecules at the beginning of the process are called substrates, and the enzyme converts them into different molecules, called the products. Almost all processes in a biological cell need enzymes to occur at significant rates. Since enzymes are selective for their substrates and speed up only a few reactions from among many possibilities, the set of enzymes made in a cell determines which metabolic pathways occur in that cell.
Like all catalysts, enzymes work by lowering the activation energy (Ea‡) for a reaction, thus dramatically increasing the rate of the reaction. Most enzyme reaction rates are millions of times faster than those of comparable un-catalyzed reactions. As with all catalysts, enzymes are not consumed by the reactions they catalyze, nor do they alter the equilibrium of these reactions. However, enzymes do differ from most other catalysts by being much more specific. Enzymes are known to catalyze about 4,000 biochemical reactions.[3] A few RNA molecules called ribozymes also catalyze reactions, with an important example being some parts of the ribosome.[4][5] Synthetic molecules called artificial enzymes also display enzyme-like catalysis.[6]
Enzyme activity can be affected by other molecules. Inhibitors are molecules that decrease enzyme activity; activators are molecules that increase activity. Many drugs and poisons are enzyme inhibitors. Activity is also affected by temperature, chemical environment (e.g., pH), and the concentration of substrate. Some enzymes are used commercially, for example, in the synthesis of antibiotics. In addition, some household products use enzymes to speed up biochemical reactions (e.g., enzymes in biological washing powders break down protein or fat stains on clothes; enzymes in meat tenderizers break down proteins, making the meat easier to chew).
Etymology and History
As early as the late 18th and early 19th centuries, the digestion of meat by stomach secretions[7] and the conversion of starch to sugars by plant extracts and saliva were known. However, the mechanism by which this occurred had not been identified.[8]
In the 19th century, when studying the fermentation of sugar to alcohol by yeast, Louis Pasteur came to the conclusion that this fermentation was catalyzed by a vital force contained within the yeast cells called "ferments", which were thought to function only within living organisms. He wrote that "alcoholic fermentation is an act correlated with the life and organization of the yeast cells, not with the death or putrefaction of the cells."[9]
In 1877, German physiologist Wilhelm Kühne (1837–1900) first used the term enzyme, which comes from Greek ενζυμον, "in leaven", to describe this process.[10] The word enzyme was used later to refer to nonliving substances such as pepsin, and the word ferment was used to refer to chemical activity produced by living organisms.
In 1897, Eduard Buchner submitted his first paper on the ability of yeast extracts that lacked any living yeast cells to ferment sugar. In a series of experiments at the University of Berlin, he found that the sugar was fermented even when there were no living yeast cells in the mixture.[11] He named the enzyme that brought about the fermentation of sucrose "zymase".[12] In 1907, he received the Nobel Prize in Chemistry "for his biochemical research and his discovery of cell-free fermentation". Following Buchner's example, enzymes are usually named according to the reaction they carry out. Typically, to generate the name of an enzyme, the suffix -ase is added to the name of its substrate (e.g., lactase is the enzyme that cleaves lactose) or the type of reaction (e.g., DNA polymerase forms DNA polymers).[13]
Having shown that enzymes could function outside a living cell, the next step was to determine their biochemical nature. Many early workers noted that enzymatic activity was associated with proteins, but several scientists (such as Nobel laureate Richard Willstätter) argued that proteins were merely carriers for the true enzymes and that proteins per se were incapable of catalysis. However, in 1926, James B. Sumner showed that the enzyme urease was a pure protein and crystallized it; Sumner did likewise for the enzyme catalase in 1937. The conclusion that pure proteins can be enzymes was definitively proved by Northrop and Stanley, who worked on the digestive enzymes pepsin (1930), trypsin and chymotrypsin. These three scientists were awarded the 1946 Nobel Prize in Chemistry.[14]
This discovery that enzymes could be crystallized eventually allowed their structures to be solved by x-ray crystallography. This was first done for lysozyme, an enzyme found in tears, saliva and egg whites that digests the coating of some bacteria; the structure was solved by a group led by David Chilton Phillips and published in 1965.[15] This high-resolution structure of lysozyme marked the beginning of the field of structural biology and the effort to understand how enzymes work at an atomic level of detail.
Structures and mechanisms
Enzymes are generally globular proteins and range from just 62 amino acid residues in size, for the monomer of 4-oxalocrotonate tautomerase,[16] to over 2,500 residues in the animal fatty acid synthase.[17] A small number of RNA-based biological catalysts exist, with the most common being the ribosome; these are referred to as either RNA-enzymes or ribozymes. The activities of enzymes are determined by their three-dimensional structure.[18] However, although structure does determine function, predicting a novel enzyme's activity just from its structure is a very difficult problem that has not yet been solved.[19]
Most enzymes are much larger than the substrates they act on, and only a small portion of the enzyme (around 3–4 amino acids) is directly involved in catalysis.[20] The region that contains these catalytic residues, binds the substrate, and then carries out the reaction is known as the active site. Enzymes can also contain sites that bind cofactors, which are needed for catalysis. Some enzymes also have binding sites for small molecules, which are often direct or indirect products or substrates of the reaction catalyzed. This binding can serve to increase or decrease the enzyme's activity, providing a means for feedback regulation.
Like all proteins, enzymes are long, linear chains of amino acids that fold to produce a three-dimensional product. Each unique amino acid sequence produces a specific structure, which has unique properties. Individual protein chains may sometimes group together to form a protein complex. Most enzymes can be denatured—that is, unfolded and inactivated—by heating or chemical denaturants, which disrupt the three-dimensional structure of the protein. Depending on the enzyme, denaturation may be reversible or irreversible.
Structures of enzymes in complex with substrates or substrate analogs during a reaction may be obtained using Time resolved crystallography methods.
Specificity
Enzymes are usually very specific as to which reactions they catalyze and the substrates that are involved in these reactions. Complementary shape, charge and hydrophilic/hydrophobic characteristics of enzymes and substrates are responsible for this specificity. Enzymes can also show impressive levels of stereospecificity, regioselectivity and chemoselectivity.[21]
Some of the enzymes showing the highest specificity and accuracy are involved in the copying and expression of the genome. These enzymes have "proof-reading" mechanisms. Here, an enzyme such as DNA polymerase catalyzes a reaction in a first step and then checks that the product is correct in a second step.[22] This two-step process results in average error rates of less than 1 error in 100 million reactions in high-fidelity mammalian polymerases.[23] Similar proofreading mechanisms are also found in RNA polymerase,[24] aminoacyl tRNA synthetases[25] and ribosomes.[26]
Some enzymes that produce secondary metabolites are described as promiscuous, as they can act on a relatively broad range of different substrates. It has been suggested that this broad substrate specificity is important for the evolution of new biosynthetic pathways.[27]
"Lock and key" model
Enzymes are very specific, and it was suggested by the Nobel laureate organic chemist Emil Fischer in 1894 that this was because both the enzyme and the substrate possess specific complementary geometric shapes that fit exactly into one another.[28] This is often referred to as "the lock and key" model. However, while this model explains enzyme specificity, it fails to explain the stabilization of the transition state that enzymes achieve.
Diagrams to show the induced fit hypothesis of enzyme action.In 1958, Daniel Koshland suggested a modification to the lock and key model: since enzymes are rather flexible structures, the active site is continually reshaped by interactions with the substrate as the substrate interacts with the enzyme.[29] As a result, the substrate does not simply bind to a rigid active site; the amino acid side chains which make up the active site are molded into the precise positions that enable the enzyme to perform its catalytic function. In some cases, such as glycosidases, the substrate molecule also changes shape slightly as it enters the active site.[30] The active site continues to change until the substrate is completely bound, at which point the final shape and charge is determined [31]. Induced fit may enhance the fidelity of molecular recognition in the presence of competition and noise via the conformational proofreading mechanism [32].
Mechanisms
Enzymes can act in several ways, all of which lower ΔG‡:[33]
Lowering the activation energy by creating an environment in which the transition state is stabilized (e.g. straining the shape of a substrate—by binding the transition-state conformation of the substrate/product molecules, the enzyme distorts the bound substrate(s) into their transition state form, thereby reducing the amount of energy required to complete the transition).
Lowering the energy of the transition state, but without distorting the substrate, by creating an environment with the opposite charge distribution to that of the transition state.
Providing an alternative pathway. For example, temporarily reacting with the substrate to form an intermediate ES complex, which would be impossible in the absence of the enzyme.
Reducing the reaction entropy change by bringing substrates together in the correct orientation to react. Considering ΔH‡ alone overlooks this effect.
Increases in temperatures speed up reactions. Thus, temperature increases help the enzyme function and develop the end product even faster. However, if heated too much, the enzyme’s shape deteriorates and only when the temperature comes back to normal does the enzyme regain its shape. Some enzymes like thermolabile enzymes work best at low temperatures.
Interestingly, this entropic effect involves destabilization of the ground state,[34] and its contribution to catalysis is relatively small.[35]
Transition State Stabilization
The understanding of the origin of the reduction of ΔG‡ requires one to find out how the enzymes can stabilize its transition state more than the transition state of the uncatalyzed reaction. Apparently, the most effective way for reaching large stabilization is the use of electrostatic effects, in particular, by having a relatively fixed polar environment that is oriented toward the charge distribution of the transition state.[36] Such an environment does not exist in the uncatalyzed reaction in water.
Dynamics and function
The internal dynamics of enzymes is linked to their mechanism of catalysis.[37][38][39] Internal dynamics are the movement of parts of the enzyme's structure, such as individual amino acid residues, a group of amino acids, or even an entire protein domain. These movements occur at various time-scales ranging from femtoseconds to seconds. Networks of protein residues throughout an enzyme's structure can contribute to catalysis through dynamic motions.[40][41][42][43] Protein motions are vital to many enzymes, but whether small and fast vibrations, or larger and slower conformational movements are more important depends on the type of reaction involved. However, although these movements are important in binding and releasing substrates and products, it is not clear if protein movements help to accelerate the chemical steps in enzymatic reactions.[44] These new insights also have implications in understanding allosteric effects and developing new drugs.
Allosteric modulation
Allosteric sites are sites on the enzyme that bind to molecules in the cellular environment. The sites form weak, noncovalent bonds with these molecules, causing a change in the conformation of the enzyme. This change in conformation translates to the active site, which then affects the reaction rate of the enzyme.[45] Allosteric interactions can both inhibit and activate enzymes and are a common way that enzymes are controlled in the body.[46]
Cofactors and coenzymes
Cofactors
Some enzymes do not need any additional components to show full activity. However, others require non-protein molecules called cofactors to be bound for activity.[47] Cofactors can be either inorganic (e.g., metal ions and iron-sulfur clusters) or organic compounds (e.g., flavin and heme). Organic cofactors can be either prosthetic groups, which are tightly bound to an enzyme, or coenzymes, which are released from the enzyme's active site during the reaction. Coenzymes include NADH, NADPH and adenosine triphosphate. These molecules transfer chemical groups between enzymes.[48]
An example of an enzyme that contains a cofactor is carbonic anhydrase, and is shown in the ribbon diagram above with a zinc cofactor bound as part of its active site.[49] These tightly bound molecules are usually found in the active site and are involved in catalysis. For example, flavin and heme cofactors are often involved in redox reactions.
Enzymes that require a cofactor but do not have one bound are called apoenzymes or apoproteins. An apoenzyme together with its cofactor(s) is called a holoenzyme (this is the active form). Most cofactors are not covalently attached to an enzyme, but are very tightly bound. However, organic prosthetic groups can be covalently bound (e.g., thiamine pyrophosphate in the enzyme pyruvate dehydrogenase). The term "holoenzyme" can also be applied to enzymes that contain multiple protein subunits, such as the DNA polymerases; here the holoenzyme is the complete complex containing all the subunits needed for activity.
Coenzymes
Coenzymes are small organic molecules that transport chemical groups from one enzyme to another.[50] Some of these chemicals such as riboflavin, thiamine and folic acid are vitamins (compounds which cannot be synthesized by the body and must be acquired from the diet). The chemical groups carried include the hydride ion (H-) carried by NAD or NADP+, the phosphate group carried by adenosine triphosphate, the acetyl group carried by coenzyme A, formyl, methenyl or methyl groups carried by folic acid and the methyl group carried by S-adenosylmethionine.
Since coenzymes are chemically changed as a consequence of enzyme action, it is useful to consider coenzymes to be a special class of substrates, or second substrates, which are common to many different enzymes. For example, about 700 enzymes are known to use the coenzyme NADH.[51]
Coenzymes are usually continuously regenerated and their concentrations maintained at a steady level inside the cell: for example, NADPH is regenerated through the pentose phosphate pathway and S-adenosylmethionine by methionine adenosyltransferase. This continuous regeneration means that even small amounts of coenzymes are used very intensively. For example, the human body turns over its own weight in ATP each day.[52]
Biological function
Enzymes serve a wide variety of functions inside living organisms. They are indispensable for signal transduction and cell regulation, often via kinases and phosphatases.[71] They also generate movement, with myosin hydrolysing ATP to generate muscle contraction and also moving cargo around the cell as part of the cytoskeleton.[72] Other ATPases in the cell membrane are ion pumps involved in active transport. Enzymes are also involved in more exotic functions, such as luciferase generating light in fireflies.[73] Viruses can also contain enzymes for infecting cells, such as the HIV integrase and reverse transcriptase, or for viral release from cells, like the influenza virus neuraminidase.
An important function of enzymes is in the digestive systems of animals. Enzymes such as amylases and proteases break down large molecules (starch or proteins, respectively) into smaller ones, so they can be absorbed by the intestines. Starch molecules, for example, are too large to be absorbed from the intestine, but enzymes hydrolyse the starch chains into smaller molecules such as maltose and eventually glucose, which can then be absorbed. Different enzymes digest different food substances. In ruminants which have herbivorous diets, microorganisms in the gut produce another enzyme, cellulase to break down the cellulose cell walls of plant fiber.[74]
Glycolytic enzymes and their functions in the metabolic pathway of glycolysisSeveral enzymes can work together in a specific order, creating metabolic pathways. In a metabolic pathway, one enzyme takes the product of another enzyme as a substrate. After the catalytic reaction, the product is then passed on to another enzyme. Sometimes more than one enzyme can catalyze the same reaction in parallel, this can allow more complex regulation: with for example a low constant activity being provided by one enzyme but an inducible high activity from a second enzyme.
Enzymes determine what steps occur in these pathways. Without enzymes, metabolism would neither progress through the same steps, nor be fast enough to serve the needs of the cell. Indeed, a metabolic pathway such as glycolysis could not exist independently of enzymes. Glucose, for example, can react directly with ATP to become phosphorylated at one or more of its carbons. In the absence of enzymes, this occurs so slowly as to be insignificant. However, if hexokinase is added, these slow reactions continue to take place except that phosphorylation at carbon 6 occurs so rapidly that if the mixture is tested a short time later, glucose-6-phosphate is found to be the only significant product. Consequently, the network of metabolic pathways within each cell depends on the set of functional enzymes that are present.
Control of activity
There are five main ways that enzyme activity is controlled in the cell.
Enzyme production (transcription and translation of enzyme genes) can be enhanced or diminished by a cell in response to changes in the cell's environment. This form of gene regulation is called enzyme induction and inhibition (see enzyme induction). For example, bacteria may become resistant to antibiotics such as penicillin because enzymes called beta-lactamases are induced that hydrolyse the crucial beta-lactam ring within the penicillin molecule. Another example are enzymes in the liver called cytochrome P450 oxidases, which are important in drug metabolism. Induction or inhibition of these enzymes can cause drug interactions.
Enzymes can be compartmentalized, with different metabolic pathways occurring in different cellular compartments. For example, fatty acids are synthesized by one set of enzymes in the cytosol, endoplasmic reticulum and the Golgi apparatus and used by a different set of enzymes as a source of energy in the mitochondrion, through β-oxidation.[75]
Enzymes can be regulated by inhibitors and activators. For example, the end product(s) of a metabolic pathway are often inhibitors for one of the first enzymes of the pathway (usually the first irreversible step, called committed step), thus regulating the amount of end product made by the pathways. Such a regulatory mechanism is called a negative feedback mechanism, because the amount of the end product produced is regulated by its own concentration. Negative feedback mechanism can effectively adjust the rate of synthesis of intermediate metabolites according to the demands of the cells. This helps allocate materials and energy economically, and prevents the manufacture of excess end products. The control of enzymatic action helps to maintain a stable internal environment in living organisms.
Enzymes can be regulated through post-translational modification. This can include phosphorylation, myristoylation and glycosylation. For example, in the response to insulin, the phosphorylation of multiple enzymes, including glycogen synthase, helps control the synthesis or degradation of glycogen and allows the cell to respond to changes in blood sugar.[76] Another example of post-translational modification is the cleavage of the polypeptide chain. Chymotrypsin, a digestive protease, is produced in inactive form as chymotrypsinogen in the pancreas and transported in this form to the stomach where it is activated. This stops the enzyme from digesting the pancreas or other tissues before it enters the gut. This type of inactive precursor to an enzyme is known as a zymogen.
Some enzymes may become activated when localized to a different environment (e.g. from a reducing (cytoplasm) to an oxidizing (periplasm) environment, high pH to low pH etc.). For example, hemagglutinin in the influenza virus is activated by a conformational change caused by the acidic conditions, these occur when it is taken up inside its host cell and enters the lysosome.[77]
Involvement in disease
Phenylalanine hydroxylase. Created from PDB 1KW0Since the tight control of enzyme activity is essential for homeostasis, any malfunction (mutation, overproduction, underproduction or deletion) of a single critical enzyme can lead to a genetic disease. The importance of enzymes is shown by the fact that a lethal illness can be caused by the malfunction of just one type of enzyme out of the thousands of types present in our bodies.
One example is the most common type of phenylketonuria. A mutation of a single amino acid in the enzyme phenylalanine hydroxylase, which catalyzes the first step in the degradation of phenylalanine, results in build-up of phenylalanine and related products. This can lead to mental retardation if the disease is untreated.[78]
Another example is when germline mutations in genes coding for DNA repair enzymes cause hereditary cancer syndromes such as xeroderma pigmentosum. Defects in these enzymes cause cancer since the body is less able to repair mutations in the genome. This causes a slow accumulation of mutations and results in the development of many types of cancer in the sufferer.
References
1. ^ Smith AL (Ed) et al. (1997). Oxford dictionary of biochemistry and molecular biology. Oxford [Oxfordshire]: Oxford University Press. ISBN 0-19-854768-4.
2. ^ Grisham, Charles M.; Reginald H. Garrett (1999). Biochemistry. Philadelphia: Saunders College Pub. pp. 426–7. ISBN 0-03-022318-0.
3.^ Bairoch A. (2000). "The ENZYME database in 2000" (PDF). Nucleic Acids Res 28 (1): 304–5. doi:10.1093/nar/28.1.304. PMID 10592255. PMC 102465. http://www.expasy.org/NAR/enz00.pdf.
4. ^ Lilley D (2005). "Structure, folding and mechanisms of ribozymes". Curr Opin Struct Biol 15 (3): 313–23. doi:10.1016/j.sbi.2005.05.002. PMID 15919196.
5. ^ Cech T (2000). "Structural biology. The ribosome is a ribozyme". Science 289 (5481): 878–9. doi:10.1126/science.289.5481.878. PMID 10960319.
6. ^ Groves JT (1997). "Artificial enzymes. The importance of being selective". Nature 389 (6649): 329–30. doi:10.1038/38602. PMID 9311771.
7. ^ de Réaumur, RAF (1752). "Observations sur la digestion des oiseaux". Histoire de l'academie royale des sciences 1752: 266, 461.
8. ^ Williams, H. S. (1904) A History of Science: in Five Volumes. Volume IV: Modern Development of the Chemical and Biological Sciences Harper and Brothers (New York) Accessed 4 April 2007
9. ^ Dubos J. (1951). "Louis Pasteur: Free Lance of Science, Gollancz. Quoted in Manchester K. L. (1995) Louis Pasteur (1822–1895)—chance and the prepared mind". Trends Biotechnol 13 (12): 511–5. doi:10.1016/S0167-7799(00)89014-9. PMID 8595136.
10. ^ Kühne coined the word "enzyme" in: W. Kühne (1877) "Über das Verhalten verschiedener organisirter und sog. ungeformter Fermente" (On the behavior of various organized and so-called unformed ferments), Verhandlungen des naturhistorisch-medicinischen Vereins zu Heidelberg, new series, vol. 1, no. 3, pages 190-193. The relevant passage occurs on page 190: "Um Missverständnissen vorzubeugen und lästige Umschreibungen zu vermeiden schlägt Vortragender vor, die ungeformten oder nicht organisirten Fermente, deren Wirkung ohne Anwesenheit von Organismen und ausserhalb derselben erfolgen kann, als Enzyme zu bezeichnen." (Translation: In order to obviate misunderstandings and avoid cumbersome periphrases, [the author, a university lecturer] suggests designating as "enzymes" the unformed or not organized ferments, whose action can occur without the presence of organisms and outside of the same.)
11. ^ Nobel Laureate Biography of Eduard Buchner at http://nobelprize.org. Retrieved 4 April 2007.
12. ^ Text of Eduard Buchner's 1907 Nobel lecture at http://nobelprize.org. Retrieved 4 April 2007.
13. ^ The naming of enzymes by adding the suffix "-ase" to the substrate on which the enzyme acts, has been traced to French scientist Émile Duclaux (1840-1904), who intended to honor the discoverers of diastase -- the first enzyme to be isolated -- by introducing this practice in his book Traité de Microbiologie, vol. 2 (Paris, France: Masson and Co., 1899). See Chapter 1, especially page 9.
14. ^ 1946 Nobel prize for Chemistry laureates at http://nobelprize.org. Retrieved 4 April 2007.
15. ^ Blake CC, Koenig DF, Mair GA, North AC, Phillips DC, Sarma VR. (1965). "Structure of hen egg-white lysozyme. A three-dimensional Fourier synthesis at 2 Angstrom resolution". Nature 22 (206): 757–61. doi:10.1038/206757a0. PMID 5891407.
16. ^ Chen LH, Kenyon GL, Curtin F, Harayama S, Bembenek ME, Hajipour G, Whitman CP (1992). "4-Oxalocrotonate tautomerase, an enzyme composed of 62 amino acid residues per monomer". J. Biol. Chem. 267 (25): 17716–21. PMID 1339435.
17. ^ Smith S (1 December 1994). "The animal fatty acid synthase: one gene, one polypeptide, seven enzymes". FASEB J. 8 (15): 1248–59. PMID 8001737. http://www.fasebj.org/cgi/reprint/8/15/1248.
18. ^ Anfinsen C.B. (1973). "Principles that Govern the Folding of Protein Chains". Science 181 (96): 223–30. doi:10.1126/science.181.4096.223. PMID 4124164.
19. ^ Dunaway-Mariano D (November 2008). "Enzyme function discovery". Structure 16 (11): 1599–600. doi:10.1016/j.str.2008.10.001. PMID 19000810.
20. ^ The Catalytic Site Atlas at The European Bioinformatics Institute. Retrieved 4 April 2007.
21. ^ Jaeger KE, Eggert T. (2004). "Enantioselective biocatalysis optimized by directed evolution". Curr Opin Biotechnol. 15 (4): 305–13. doi:10.1016/j.copbio.2004.06.007. PMID 15358000.
22. ^ Shevelev IV, Hubscher U. (2002). "The 3' 5' exonucleases". Nat Rev Mol Cell Biol. 3 (5): 364–76. doi:10.1038/nrm804. PMID 11988770.
23. ^ Tymoczko, John L.; Stryer Berg Tymoczko; Stryer, Lubert; Berg, Jeremy Mark (2002). Biochemistry. San Francisco: W.H. Freeman. ISBN 0-7167-4955-6.
24. ^ Zenkin N, Yuzenkova Y, Severinov K. (2006). "Transcript-assisted transcriptional proofreading". Science. 313 (5786): 518–20. doi:10.1126/science.1127422. PMID 16873663.
25. ^ Ibba M, Soll D. (2000). "Aminoacyl-tRNA synthesis". Annu Rev Biochem. 69: 617–50. doi:10.1146/annurev.biochem.69.1.617. PMID 10966471.
26. ^ Rodnina MV, Wintermeyer W. (2001). "Fidelity of aminoacyl-tRNA selection on the ribosome: kinetic and structural mechanisms". Annu Rev Biochem. 70: 415–35. doi:10.1146/annurev.biochem.70.1.415. PMID 11395413.
27. ^ Firn, Richard. "The Screening Hypothesis - a new explanation of secondary product diversity and function". http://www-users.york.ac.uk/~drf1/rdf_sp1.htm. Retrieved 2006-10-11.
28. ^ Fischer E. (1894). "Einfluss der Configuration auf die Wirkung der Enzyme". Ber. Dt. Chem. Ges. 27: 2985–93. doi:10.1002/cber.18940270364. http://gallica.bnf.fr/ark:/12148/bpt6k90736r/f364.chemindefer.
29. ^ Koshland D. E. (1958). "Application of a Theory of Enzyme Specificity to Protein Synthesis". Proc. Natl. Acad. Sci. 44 (2): 98–104. doi:10.1073/pnas.44.2.98. PMID 16590179.
30. ^ Vasella A, Davies GJ, Bohm M. (2002). "Glycosidase mechanisms". Curr Opin Chem Biol. 6 (5): 619–29. doi:10.1016/S1367-5931(02)00380-0. PMID 12413546.
31. ^ Boyer, Rodney (2002) [2002]. "6". Concepts in Biochemistry (2nd ed.). New York, Chichester, Weinheim, Brisbane, Singapore, Toronto.: John Wiley & Sons, Inc.. pp. 137–8. ISBN 0-470-00379-0. OCLC 51720783.
32. ^ Savir Y & Tlusty T (2007). "Conformational proofreading: the impact of conformational changes on the specificity of molecular recognition". PLoS ONE 2: e468. http://www.weizmann.ac.il/complex/tlusty/papers/PLoSONE2007.pdf.
33. ^ Fersht, Alan (1985). Enzyme structure and mechanism. San Francisco: W.H. Freeman. pp. 50–2. ISBN 0-7167-1615-1.
34. ^ Jencks, William P. (1987). Catalysis in chemistry and enzymology. Mineola, N.Y: Dover. ISBN 0-486-65460-5.
35. ^ Villa J, Strajbl M, Glennon TM, Sham YY, Chu ZT, Warshel A (2000). "How important are entropic contributions to enzyme catalysis?". Proc. Natl. Acad. Sci. U.S.A. 97 (22): 11899–904. doi:10.1073/pnas.97.22.11899. PMID 11050223.
36. ^ Warshel A, Sharma PK, Kato M, Xiang Y, Liu H, Olsson MH (2006). "Electrostatic basis for enzyme catalysis". Chem. Rev. 106 (8): 3210–35. doi:10.1021/cr0503106. PMID 16895325.
37. ^ Eisenmesser EZ, Bosco DA, Akke M, Kern D (February 2002). "Enzyme dynamics during catalysis". Science 295 (5559): 1520–3. doi:10.1126/science.1066176. PMID 11859194.
38. ^ Agarwal PK (November 2005). "Role of protein dynamics in reaction rate enhancement by enzymes". J. Am. Chem. Soc. 127 (43): 15248–56. doi:10.1021/ja055251s. PMID 16248667.
39. ^ Eisenmesser EZ, Millet O, Labeikovsky W (November 2005). "Intrinsic dynamics of an enzyme underlies catalysis". Nature 438 (7064): 117–21. doi:10.1038/nature04105. PMID 16267559.
40. ^ Yang LW, Bahar I (5 June 2005). "Coupling between catalytic site and collective dynamics: A requirement for mechanochemical activity of enzymes". Structure 13 (6): 893–904. doi:10.1016/j.str.2005.03.015. PMID 15939021. PMC 1489920. http://www.cell.com/structure/abstract/S0969-2126%2805%2900167-X.
41. ^ Agarwal PK, Billeter SR, Rajagopalan PT, Benkovic SJ, Hammes-Schiffer S. (5 March 2002). "Network of coupled promoting motions in enzyme catalysis". Proc Natl Acad Sci USA. 99 (5): 2794–9. doi:10.1073/pnas.052005999. PMID 11867722.
42. ^ Agarwal PK, Geist A, Gorin A (August 2004). "Protein dynamics and enzymatic catalysis: investigating the peptidyl-prolyl cis-trans isomerization activity of cyclophilin A". Biochemistry 43 (33): 10605–18. doi:10.1021/bi0495228. PMID 15311922.
43. ^ Tousignant A, Pelletier JN. (August 2004). "Protein motions promote catalysis". Chem Biol. 11 (8): 1037–42. doi:10.1016/j.chembiol.2004.06.007. PMID 15324804. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRP-4D4JYMC-6&_coverDate=08%2F31%2F2004&_alid=465962916&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6240&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=613585a6164baa38b4f6536d8da9170a.
44. ^ Olsson, MH; Parson, WW; Warshel, A (2006). "Dynamical Contributions to Enzyme Catalysis: Critical Tests of A Popular Hypothesis". Chem. Rev. 106 (5): 1737–56. doi:10.1021/cr040427e. PMID 16683752.
45. ^ Neet KE (1995). "Cooperativity in enzyme function: equilibrium and kinetic aspects". Meth. Enzymol. 249: 519–67. doi:10.1016/0076-6879(95)49048-5. PMID 7791626.
46. ^ Changeux JP, Edelstein SJ (June 2005). "Allosteric mechanisms of signal transduction". Science 308 (5727): 1424–8. doi:10.1126/science.1108595. PMID 15933191.
47. ^ de Bolster, M.W.G. (1997). "Glossary of Terms Used in Bioinorganic Chemistry: Cofactor". International Union of Pure and Applied Chemistry. http://www.chem.qmul.ac.uk/iupac/bioinorg/CD.html#34. Retrieved 2007-10-30.
48. ^ de Bolster, M.W.G. (1997). "Glossary of Terms Used in Bioinorganic Chemistry: Coenzyme". International Union of Pure and Applied Chemistry. http://www.chem.qmul.ac.uk/iupac/bioinorg/CD.html#33. Retrieved 2007-10-30.
49. ^ Fisher Z, Hernandez Prada JA, Tu C, Duda D, Yoshioka C, An H, Govindasamy L, Silverman DN and McKenna R. (2005). "Structural and kinetic characterization of active-site histidine as a proton shuttle in catalysis by human carbonic anhydrase II". Biochemistry. 44 (4): 1097–115. doi:10.1021/bi0480279. PMID 15667203.
50. ^ Wagner, Arthur L. (1975). Vitamins and Coenzymes. Krieger Pub Co. ISBN 0-88275-258-8.
51. ^ BRENDA The Comprehensive Enzyme Information System. Retrieved 4 April 2007.
52. ^ Törnroth-Horsefield S, Neutze R (December 2008). "Opening and closing the metabolite gate". Proc. Natl. Acad. Sci. U.S.A. 105 (50): 19565–6. doi:10.1073/pnas.0810654106. PMID 19073922. PMC 2604989. http://www.pnas.org/cgi/pmidlookup?view=long&pmid=19073922.
53. ^ Ferguson, S. J.; Nicholls, David; Ferguson, Stuart (2002). Bioenergetics 3 (3rd ed.). San Diego: Academic. ISBN 0-12-518121-3.
54. ^ Henri, V. (1902). "Theorie generale de l'action de quelques diastases". Compt. Rend. Hebd. Acad. Sci. Paris 135: 916–9.
55. ^ Sørensen,P.L. (1909). "Enzymstudien {II}. Über die Messung und Bedeutung der Wasserstoffionenkonzentration bei enzymatischen Prozessen". Biochem. Z. 21: 131–304.
56. ^ Michaelis L., Menten M. (1913). "Die Kinetik der Invertinwirkung". Biochem. Z. 49: 333–369. English translation. Retrieved 6 April 2007.
57. ^ Briggs G. E., Haldane J. B. S. (1925). "A note on the kinetics of enzyme action". Biochem. J. 19 (2): 339–339. PMID 16743508. PMC 1259181. http://www.biochemj.org/bj/019/0338/bj0190338_browse.htm.
58. ^ Radzicka A, Wolfenden R. (1995). "A proficient enzyme". Science 6 (267): 90–931. doi:10.1126/science.7809611. PMID 7809611.
59. ^ Ellis RJ (2001). "Macromolecular crowding: obvious but underappreciated". Trends Biochem. Sci. 26 (10): 597–604. doi:10.1016/S0968-0004(01)01938-7. PMID 11590012.
60. ^ Kopelman R (1988). "Fractal Reaction Kinetics". Science 241 (4873): 1620–26. doi:10.1126/science.241.4873.1620. PMID 17820893.
61. ^ Savageau MA (1995). "Michaelis-Menten mechanism reconsidered: implications of fractal kinetics". J. Theor. Biol. 176 (1): 115–24. doi:10.1006/jtbi.1995.0181. PMID 7475096.
62. ^ Schnell S, Turner TE (2004). "Reaction kinetics in intracellular environments with macromolecular crowding: simulations and rate laws". Prog. Biophys. Mol. Biol. 85 (2–3): 235–60. doi:10.1016/j.pbiomolbio.2004.01.012. PMID 15142746.
63. ^ Xu F, Ding H (2007). "A new kinetic model for heterogeneous (or spatially confined) enzymatic catalysis: Contributions from the fractal and jamming (overcrowding) effects". Appl. Catal. A: Gen. 317 (1): 70–81. doi:10.1016/j.apcata.2006.10.014.
64. ^ Garcia-Viloca M., Gao J., Karplus M., Truhlar D. G. (2004). "How enzymes work: analysis by modern rate theory and computer simulations". Science 303 (5655): 186–95. doi:10.1126/science.1088172. PMID 14716003.
65. ^ Olsson M. H., Siegbahn P. E., Warshel A. (2004). "Simulations of the large kinetic isotope effect and the temperature dependence of the hydrogen atom transfer in lipoxygenase". J. Am. Chem. Soc. 126 (9): 2820–8. doi:10.1021/ja037233l. PMID 14995199.
66. ^ Masgrau L., Roujeinikova A., Johannissen L. O., Hothi P., Basran J., Ranaghan K. E., Mulholland A. J., Sutcliffe M. J., Scrutton N. S., Leys D. (2006). "Atomic Description of an Enzyme Reaction Dominated by Proton Tunneling". Science 312 (5771): 237–41. doi:10.1126/science.1126002. PMID 16614214.
67 .^ Cleland, W.W. (1963). "The Kinetics of Enzyme-catalyzed Reactions with two or more Substrates or Products 2. {I}nhibition: Nomenclature and Theory". Biochim. Biophys. Acta 67: 173–87.
68. ^ Price, NC. (1979). "What is meant by ‘competitive inhibition’?". Trends in Biochemical Sciences 4: pN272.
69. ^ Poulin R, Lu L, Ackermann B, Bey P, Pegg AE. Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sites. J Biol Chem. 1992 January 5;267(1):150–8. PMID 1730582
70. ^ Yoshikawa S and Caughey WS. (15 May 1990). "Infrared evidence of cyanide binding to iron and copper sites in bovine heart cytochrome c oxidase. Implications regarding oxygen reduction". J Biol Chem. 265 (14): 7945–58. PMID 2159465. http://www.jbc.org/cgi/reprint/265/14/7945.
71. ^ Hunter T. (1995). "Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling". Cell. 80 (2): 225–36. doi:10.1016/0092-8674(95)90405-0. PMID 7834742.
72. ^ Berg JS, Powell BC, Cheney RE (1 April 2001). "A millennial myosin census". Mol. Biol. Cell 12 (4): 780–94. PMID 11294886. PMC 32266. http://www.molbiolcell.org/cgi/content/full/12/4/780.
73. ^ Meighen EA (1 March 1991). "Molecular biology of bacterial bioluminescence". Microbiol. Rev. 55 (1): 123–42. PMID 2030669. PMC 372803. http://mmbr.asm.org/cgi/reprint/55/1/123?view=long&pmid=2030669.
74. ^ Mackie RI, White BA (1 October 1990). "Recent advances in rumen microbial ecology and metabolism: potential impact on nutrient output". J. Dairy Sci. 73 (10): 2971–95. doi:10.3168/jds.S0022-0302(90)78986-2. PMID 2178174. http://jds.fass.org/cgi/reprint/73/10/2971.
75. ^ Faergeman NJ, Knudsen J (April 1997). "Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling". Biochem. J. 323 (Pt 1): 1–12. PMID 9173866. PMC 1218279. http://www.biochemj.org/bj/323/0001/bj3230001.htm.
76. ^ Doble B. W., Woodgett J. R. (April 2003). "GSK-3: tricks of the trade for a multi-tasking kinase". J. Cell. Sci. 116 (Pt 7): 1175–86. doi:10.1242/jcs.00384. PMID 12615961. http://jcs.biologists.org/cgi/content/full/116/7/1175.
77. ^ Carr C. M., Kim P. S. (April 2003). "A spring-loaded mechanism for the conformational change of influenza hemagglutinin". Cell 73 (4): 823–32. doi:10.1016/0092-8674(93)90260-W. PMID 8500173.
78. ^ Phenylketonuria: NCBI Genes and Disease. Retrieved 4 April 2007.
79. ^ Shen H. B., Chou K. C. (2007) EzyPred: A top-down approach for predicting enzyme functional classes and subclasses. Biochem Biophys Res Comm 364, 53-59.
80. ^ Qiu J. D., Huang J. H., Shi S. P., Liang R. P. (2010) Using the Concept of Chou's Pseudo Amino Acid Composition to Predict Enzyme Family Classes: An Approach with Support Vector Machine Based on Discrete Wavelet Transform. ‘’Protein & Peptide Letters’’ 17, 715-712.
81. ^ Zhou, X. B., Chen, C., Li, Z. C. & Zou, X. Y. (2007) Using Chou's amphiphilic pseudo-amino acid composition and support vector machine for prediction of enzyme subfamily classes. Journal of Theoretical Biology 248, 546–551.
82. ^ Chou K. C. (2005) Using amphiphilic pseudo amino acid composition to predict enzyme subfamily classes. Bioinformatics 21, 10-19.
83. ^ Renugopalakrishnan V, Garduno-Juarez R, Narasimhan G, Verma CS, Wei X, Li P. (2005). "Rational design of thermally stable proteins: relevance to bionanotechnology". J Nanosci Nanotechnol. 5 (11): 1759–1767. doi:10.1166/jnn.2005.441. PMID 16433409.
84. ^ Hult K, Berglund P. (2003). "Engineered enzymes for improved organic synthesis". Curr Opin Biotechnol. 14 (4): 395–400. doi:10.1016/S0958-1669(03)00095-8. PMID 12943848.
85. ^ Jiang L, Althoff EA, Clemente FR (March 2008). "De novo computational design of retro-aldol enzymes". Science (journal) 319 (5868): 1387–91. doi:10.1126/science.1152692. PMID 18323453.
86. ^ Guzmán-Maldonado H, Paredes-López O (September 1995). "Amylolytic enzymes and products derived from starch: a review". Critical reviews in food science and nutrition 35 (5): 373–403. doi:10.1080/10408399509527706. PMID 8573280.
87. ^ Dulieu C, Moll M, Boudrant J, Poncelet D (2000). "Improved performances and control of beer fermentation using encapsulated alpha-acetolactate decarboxylase and modeling". Biotechnology progress 16 (6): 958–65. doi:10.1021/bp000128k. PMID 11101321.